Allografts

We are the Clinical Support Partner for Australian Biotechnologies in the Plastic, Reconstructive, ENT, Urogynaecological, Oral Maxillofacial and Dental specialties. Australian Biotechnologies has a 23-year history in allograft manufacturing. Their mission is to honour the gift of donation while delivering life enhancing allografts to the Australian community. Through this partnership, Samson Medical Technologies has initiated many innovative new product developments that provide a dedicated range of osteoconductive and osteoinductive allografts to the Plastic, Reconstructive, ENT, Urogynaecological, Oral Maxillofacial and Dental specialties. To date Australian Biotechnologies have supplied over 150,000 allografts to 90,000+ Australians.

Our Urogynaecology allograft portfolio includes a dynamic soft tissue graft designed to support pelvic floor reconstruction and complex urogynaecological procedures. Derived from carefully processed human donor tissue, these allografts are available in multiple configurations to meet the varying anatomical and surgical requirements of pelvic reconstructive surgery. Fascia lata allografts are widely utilised in the management of stress urinary incontinence and pelvic organ prolapse. Their inherent tensile strength, flexibility, and biocompatibility make them well suited for sling procedures, fascial reinforcement, and soft tissue support. Used as an alternative to autologous fascia harvest, fascia lata allografts provide reliable structural support while reducing operative time, patient morbidity, and donor site complications. Fascia Lata allograft offers surgeons an effective biological solution for pelvic floor repair, enhancing surgical outcomes while eliminating the need for secondary donor site procedures.